NURO Neurometrix Inc

NeuroMetrix Inc manufactures and sells wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests that help patients and physicians manage chronic pain, nerve diseases, and sleep disorders.

As of 05/07/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  07/22/2004
Outstanding shares:  3,803,195
Average volume:  79,075
Market cap:   $10,877,138
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    641255807
ISIN:        US6412558073
Sedol:      BL4KMB7
Valuation   (See tab for details)
PE ratio:   -7.43
PB ratio:   2.11
PS ratio:   1.48
Return on equity:   -22.18%
Net income %:   -15.85%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy